Proact - Growth is slowing but costs are addressed - ABG

• -2% organic growth (ABGe 3%) amid tough comps
• Adj. EBITA +10% vs cons, initiates cost reduction program
• Estimates and share relatively neutral

Q2 details
Q2'23 report: Sales SEK 1,202m (-2% vs ABG 1,230m, -3% vs cons 1,242m), Adj. EBITA 81m (12% vs ABG 73m, 10% vs cons 74m), Adj. EBITA margin 6.8% (ABG 5.9%, cons 6.0%). Organic sales growth -2% vs ABG 3%, no cons), of which system sales declined -9 % organically and services grew 9%.

Länk till analysen i sin helhet: https://cr.abgsc.com/contentassets/1512bc1c1a8a44c489d063b85d30dd21/pdf/growth-is-slowing-but-costs-are-addressed.pdf